Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Huan Chau Lin"'
Autor:
Chun-Chia Cheng, Po-Nien Liao, Ai-Sheng Ho, Ken-Hong Lim, Jungshan Chang, Ying-Wen Su, Caleb Gon-Shen Chen, Ya-Wen Chiang, Bi-Ling Yang, Huan-Chau Lin, Yu-Cheng Chang, Chun-Chao Chang, Yi-Fang Chang
Publikováno v:
Journal of Biomedical Science, Vol 25, Iss 1, Pp 1-12 (2018)
Abstract Background Cancer stem cells are capable of undergoing cell division after surviving cancer therapies, leading to tumor progression and recurrence. Inhibitory agents against cancer stem cells may be therapeutically used for efficiently eradi
Externí odkaz:
https://doaj.org/article/6fa8fbb263aa47dc8b21de866be2cfc8
Autor:
Ying‐Wen Su, Wen‐Yu Huang, Huan‐Chau Lin, Po‐Nien Liao, Ching‐Yung Lin, Xiang‐Yu Lin, Sing‐Han Huang, Yi‐Ting Chen, Pao‐Shu Wu
Publikováno v:
Journal of Oral Pathology & Medicine. 52:245-254
Accumulating evidence shows that high expression of casein kinase 2 (CK2) and phosphorylated acetyl CoA carboxylase (pACC) in patients with squamous cell carcinoma of the head and neck (SCCHN) correlates with decreased survival rates. Computational a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17637f385fc37c5faa4a59febdf1771b
https://doi.org/10.1111/jop.13378
https://doi.org/10.1111/jop.13378
Publikováno v:
International Journal of Gerontology; Oct2023, Vol. 17 Issue 4, p247-253, 7p
Autor:
Chun-Chia Cheng, Jungshan Chang, Stanley Ching-Cheng Huang, Huan-Chau Lin, Ai-Sheng Ho, Ken-Hong Lim, Chun-Chao Chang, Ling Huang, Yu-Cheng Chang, Yi-Fang Chang, Cheng-Wen Wu
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182149 (2017)
Cancer stem cell survival is the leading factor for tumor recurrence after tumor-suppressive treatments. Therefore, specific and efficient inhibitors of cancer stemness must be discovered for reducing tumor recurrence. YM155 has been indicated to sig
Externí odkaz:
https://doaj.org/article/60ce4b2bc6fc42939c1b03b8255c5c8d
Autor:
Jo-Ning Wu, Johnson Lin, Yu-Cheng Chang, Caleb Gon-Shen Chen, Ying-Wen Su, Jie-Yang Jhuang, Yi-Fang Chang, Ken-Hong Lim, To-Yu Huang, Yi-Hao Chiang, Huan-Chau Lin
Publikováno v:
Blood Adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b761f82f8579545f98e365c6f490b3cb
https://doi.org/10.1182/bloodadvances.2020003980
https://doi.org/10.1182/bloodadvances.2020003980
Autor:
Huan-Chau Lin, Caleb Gon-Shen Chen, Ming-Chih Chang, Wei-Ting Wang, Chen Wei Kao, An-Chi Lo, Nai-Wen Su, Yu-Cheng Chang, Yi-Hao Chiang, Kuei-Fang Chou, Po-Nien Liao, Guan-Jhe Cai, Hung-I Cheng, Johnson Lin, Yi-Fang Chang, Ruey-Kuen Hsieh, Ken-Hong Lim
Publikováno v:
International Journal of Gerontology, Vol 7, Iss 1, Pp 40-44 (2013)
Background: Essential thrombocythemia (ET) is classified as a chronic myeloproliferative neoplasm. JAK2 V617F mutation is found in about 50–60% patients with ET. We aim to determine the prevalence of JAK2 V617F mutation and its association with phe
Externí odkaz:
https://doaj.org/article/5f37be7a6b3a4ffc9382b114777bd644
Autor:
Nai-Wen Su, Lai-Man Mok, Mei-Lin Chan, Hung-Chang Liu, Wei-Chin Chang, Chun-Ho Yun, Tze-Yu Shieh, Ming-Che Wu, Huan-Chau Lin, Wen-Chien Huang, Yu-Jen Chen
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1122
Volume 15
Issue 4
Pages: 1122
Neoadjuvant chemoradiotherapy (neoCRT) followed by surgery is the cornerstone treatment strategy in locally advanced esophageal squamous cell carcinoma (ESCC). Despite this high- intensity multimodality therapy, most patients still experience recurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba62ac9d353315f14586278ae7c3317
https://doi.org/10.3390/cancers15041122
https://doi.org/10.3390/cancers15041122
Autor:
Huan-Chau Lin, Ferry Saputra, Gilbert Audira, Yu-Heng Lai, Marri Jmelou M. Roldan, Honeymae C. Alos, Charlaine A. Aventurado, Ross D. Vasquez, Guan-Jhe Tsai, Ken-Hong Lim, Chung-Der Hsiao
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 19; Pages: 11711
BCR-ABL, a fusion protein kinase, is a druggable target exclusively expressed in patients with chronic myeloid leukemia (CML). Several anti-leukemia medicines targeting this protein have been developed in recent years. However, therapeutic options ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2832b35901f16cb089076ca73e41f10f
https://doi.org/10.3390/ijms231911711
https://doi.org/10.3390/ijms231911711
Autor:
Huan-Chau Lin, Shu-Ching Wang, Caleb Gon-Shen Chen, Ming-Chih Chang, Wei-Ting Wang, Nai-Wen Su, Hung-I Cheng, Johnson Lin, Yi-Fang Chang, Ruey-Kuen Hsieh, Chien-Chung Chang, Yuchi Hwang, Ken-Hong Lim, Yuan-Yeh Kuo
Publikováno v:
International Journal of Gerontology, Vol 7, Iss 3, Pp 186-188 (2013)
In addition to the JAK2 V617F mutation, somatic mutation in DNMT3A has been described in BCL-ABL1-negative myeloproliferative neoplasms (MPNs). We have screened for DNMT3A exon 23 mutations in 130 adult Taiwanese patients with chronic phase myeloprol
Externí odkaz:
https://doaj.org/article/8da35d0012b24a9892ca26cdea777184
Autor:
Sung-Tzu Liang, Yu-Heng Lai, Chung-Der Hsiao, Erwei Hao, Petrus Siregar, Michael Edbert Suryanto, Omar Villalobos, Oliver B. Villaflores, Gilbert Audira, Ken-Hong Lim, Huan-Chau Lin
Publikováno v:
Genes, Vol 11, Iss 1322, p 1322 (2020)
Genes
Volume 11
Issue 11
Genes
Volume 11
Issue 11
DNA methylation plays several roles in regulating neuronal proliferation, differentiation, and physiological functions. The major de novo methyltransferase, DNMT3, controls the DNA methylation pattern in neurons according to environmental stimulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a2dc7538724b7728c2608d610b5448e
https://www.mdpi.com/2073-4425/11/11/1322
https://www.mdpi.com/2073-4425/11/11/1322